These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6094125)

  • 1. Dopamine depletion and replacement.
    Ciba Found Symp; 1984; 107():216-24. PubMed ID: 6094125
    [No Abstract]   [Full Text] [Related]  

  • 2. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease.
    Brown P
    Mov Disord; 2003 Apr; 18(4):357-63. PubMed ID: 12671940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problem of storage and synaptic processes in the brain].
    Fischel W
    Psychiatr Neurol Med Psychol (Leipz); 1974 Feb; 26(2):65-9. PubMed ID: 4366913
    [No Abstract]   [Full Text] [Related]  

  • 4. [A contribution of synaptic plasticity in the basal ganglia to processing of visual information].
    Sil'kis IG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(6):742-56. PubMed ID: 17285769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implication of neuroexcitatory amino acids in the anatomo- functional organization of the central gray nucleus: physio-pathological aspects].
    Kerkerian-Le Goff L; Amalric M; Nieoullon A
    Arch Int Physiol Biochim Biophys; 1994; 102(4):A37-43. PubMed ID: 8000052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endogenous interaction of neurotransmitters and aging: studies on the basal ganglia of awake rats].
    Mora Teruel F
    An R Acad Nac Med (Madr); 1999; 116(4):729-41; discussion 741-5. PubMed ID: 10897868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the basal ganglia of amphibians: dopaminergic mesostriatal projections.
    González A; Muñoz M; Muñoz A; Marin O; Smeets WJ
    Eur J Morphol; 1994 Aug; 32(2-4):271-4. PubMed ID: 7803178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat.
    Dejean C; Gross CE; Bioulac B; Boraud T
    J Neurophysiol; 2008 Jul; 100(1):385-96. PubMed ID: 18497362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction.
    Costa RM; Lin SC; Sotnikova TD; Cyr M; Gainetdinov RR; Caron MG; Nicolelis MA
    Neuron; 2006 Oct; 52(2):359-69. PubMed ID: 17046697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia disorders. An electrophysiologic approach.
    Mercuri NB; Calabresi P; Bernardi G
    Adv Neurol; 1996; 69():117-21. PubMed ID: 8615118
    [No Abstract]   [Full Text] [Related]  

  • 11. Physiology of the normal and dopamine-depleted basal ganglia: insights into levodopa pharmacotherapy.
    Grace AA
    Mov Disord; 2008; 23 Suppl 3():S560-9. PubMed ID: 18781673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A possible mechanism of dopamine-induced synergistic disinhibition of thalamic cells via "direct" and "indirect" pathways in basal ganglia].
    Sil'kis IG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2001; 51(3):294-303. PubMed ID: 11550635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local regulation of transmitter release in the basal ganglia.
    Ciba Found Symp; 1984; 107():258-68. PubMed ID: 6149898
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between oscillations in the basal ganglia and synchronization of cortical activity.
    Cassim F; Labyt E; Devos D; Defebvre L; Destée A; Derambure P
    Epileptic Disord; 2002 Dec; 4 Suppl 3():S31-45. PubMed ID: 12495873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides in normal and pathological basal ganglia.
    Buck SH; Yamamura HI
    Adv Neurol; 1982; 35():121-32. PubMed ID: 6128884
    [No Abstract]   [Full Text] [Related]  

  • 16. GABAergic circuits in the basal ganglia and movement disorders.
    Galvan A; Wichmann T
    Prog Brain Res; 2007; 160():287-312. PubMed ID: 17499121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia.
    Tseng KY; Kargieman L; Gacio S; Riquelme LA; Murer MG
    Eur J Neurosci; 2005 Nov; 22(10):2579-86. PubMed ID: 16307600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter function in the basal ganglia after acute and chronic ethanol treatment.
    Hunt WA
    Fed Proc; 1981 May; 40(7):2077-81. PubMed ID: 6262136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of glutamate in the pathophysiology of Parkinson's disease.
    Blandini F; Greenamyre JT; Nappi G
    Funct Neurol; 1996; 11(1):3-15. PubMed ID: 8936453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.